Ga naar de inhoud

Richards Group acquires Zimed PF

Richards Group, through its subsidiary Luvo Medical Technologies, acquired Zimed PF from Aequus Pharmaceuticals.

The parties

Richards Group

Richards Group is a Canadian healthcare and packaging company founded in 1912 and headquartered in Mississauga, Ontario. The company operates across two core segments, Healthcare and Packaging. It serves a global customer base with market leading medical devices, supplies, and equipment, alongside a diverse offering of glass and plastic packaging solutions.

Richards is the largest Canadian distributor in aesthetic, pharmacy, and vision care devices. It is also the third largest packaging distributor in Canada. In addition, the company is developing a global OEM footprint in medical devices. Richards differentiates itself through product innovation, high touch service, and deep industry expertise.

Aequus Pharmaceuticals

Aequus Pharmaceuticals is a specialty pharmaceutical company. The company focuses on commercialising value-added products in specialty therapeutic areas in the Canadian market.

Outcome

This strategic acquisition strengthens Richards’ ophthalmology and vision care offering through Luvo Medical Technologies. Furthermore, it supports the continued expansion of the company’s healthcare platform in Canada. The transaction adds an established product to a distribution network with national reach, reinforcing Richards’ position as the leading Canadian distributor in vision care.

Clairfield’s role

Clairfield International acted as exclusive financial advisor to Richards Group throughout the transaction. The team advised on every stage, from identification and evaluation through negotiation and closing. Moreover, the mandate reflects Clairfield’s sector expertise and experience in advising clients on acquisitions in healthcare.

Healthcare

Drapeau Canada

Advisor to the buyer

Sectoren :

Healthcare

Countries involved :

Canada

Similar transactions

Richards Group, through its subsidiary Healthmark Services Ltd., acquired the assets of PharmaSystems Inc.’s consumer packaged goods division, a leading provider of essential over-the-counter health and wellness products to major pharmacies and retailers across Canada.

Read more

Healthcare

Drapeau Canada

Advisor to the buyer

Richards Packaging Income Fund, through its subsidiary Richards Packaging Holdings 2 Inc., acquired HL Production, the Swiss based global owner and distributor of the World PRP® platelet-rich plasma system.

Read more

Healthcare

Drapeau Canada Drapeau Switzerland

Acquisition

Advisor to the buyer

Richards Packaging Income Fund (TSX: RPI.UN), through its subsidiary Clarion Medical Technologies Inc., acquired all of the outstanding shares of National Dental Inc., a leading Canadian provider of high-tech laser and diagnostic devices to the dental care industry.

Read more

Healthcare

Drapeau Canada

Acquisition

Advisor to the buyer

Richards Packaging, a Canadian-based distributor of packaging solutions and equipment, acquired the DermapenWorld Group of companies, an Australia-based global provider of microneedling devices and dermatological cosmetics.

Read more

Healthcare

Drapeau Australia Drapeau Canada

Acquisition

Advisor to the buyer

Richards Packaging Income Fund (TSX: RPI.UN) acquired Clarion Medical Technologies, a Canadian provider of medical, aesthetic, vision care and surgical equipment and consumables.

Read more

Healthcare

Drapeau Canada

Acquisition

Advisor to the buyer

Richards Packaging Income Fund (TSX: RPI.UN) acquired Insight Medical Technologies, a vision-care distributor, through its subsidiary Clarion Medical Technologies Inc.

Healthcare

Drapeau Canada

Acquisition

Advisor to the buyer

Herantis Pharma Plc, a company developing disease-modifying therapies for Parkinson’s disease, raised equity through a directed share issue.

Healthcare

Drapeau Finland

Equity financing

Advisor to Herantis Pharma Plc

Zambon, an Italian pharmaceutical multinational, acquired the biotech Breath Therapeutics at an initial price of 140 million euros and with the possibility of reaching a total of 500 million euros at the achievement of regulatory and commercial objectives.

Healthcare

Drapeau Italy

Acquisition

Advisor to the buyer

Flèche vers la gauche
Flèche vers la droite